Pricing Log in Create free account

China Pharma Holdings, Inc. (CPHI) vs Incannex Healthcare Inc. (IXHL)

China Pharma Holdings, Inc. and Incannex Healthcare Inc. are both Drug Manufacturers Specialty & Generic companies. Incannex Healthcare Inc. is the larger, with a market value of $36.1M against $31.3M — 1.2× the size. Incannex Healthcare Inc. has the higher net margin (0.00% vs −114.3%) and the higher return on invested capital (0.00% vs −7.23%). Across the 17 metrics below, Incannex Healthcare Inc. leads on 9 and China Pharma Holdings, Inc. on 8.

Valuation

Metric CPHI IXHL Drug Manufacturers Specialty & Generic median
P/E n/m n/m 19.25
P/S 7.35 21.06 2.11
P/B 0.80 0.49 1.78
Price to free cash flow n/m n/m 16.14
EV/EBITDA n/m 1.36 12.58
EV/Sales 8.11 (19.90) 2.73
Earnings yield (60.56%) (60.71%) (4.38%)
Free cash flow yield (1.16%) (39.17%) 0.00%

Profitability

Metric CPHI IXHL Drug Manufacturers Specialty & Generic median
Gross margin 11.76% (0.10%) 53.94%
Operating margin (111.84%) 0.00% 0.00%
Net margin (114.33%) 0.00% 0.00%
Free cash flow margin (3.59%) 0.00% 0.00%
Return on equity (20.99%) (47.80%) (0.40%)
Return on assets (15.30%) (41.32%) (3.32%)
Return on invested capital (7.23%) 0.00% 0.00%

Growth

Metric CPHI IXHL Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (10.97%) — 10.01%
EPS growth (last fiscal year) 72.59% 95.91% 49.06%
Revenue growth, 5-year CAGR (17.53%) (29.64%) 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CPHI IXHL Drug Manufacturers Specialty & Generic median
Debt to equity 0.05 0.00 0.05
Current ratio 0.26 48.81 2.31
Net debt to EBITDA (0.98) 2.97 0.97

Dividend

Metric CPHI IXHL Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric CPHI IXHL Drug Manufacturers Specialty & Generic median
Market cap 31.32m 36.12m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack